Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Asset Allocation median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | UTI Multi Asset Allocation Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹95.13 |
| 12 Apr 2015 | ₹124.81 |
| 31 May 2016 | ₹119.40 |
| 19 Jul 2017 | ₹139.80 |
| 07 Sep 2018 | ₹150.88 |
| 27 Oct 2019 | ₹151.44 |
| 15 Dec 2020 | ₹173.56 |
| 03 Feb 2022 | ₹199.66 |
| 25 Mar 2023 | ₹206.99 |
| 12 May 2024 | ₹303.91 |
| 01 Jul 2025 | ₹349.62 |
| 20 Aug 2026 | ₹378.59 |
| Metric | UTI · Direct NAV ₹89.88 High risk ★★☆☆☆ | Category median Multi Asset Allocation · 36 funds |
|---|---|---|
| +8.58% | +14.93% | |
| +17.51% | +16.67% | |
| +14.54% | +14.54% | |
| +11.49% | +12.15% | |
| +10.26% | +13.94% | |
| +15.02% | — | |
| +11.18% | +16.84% | |
| +10.47% | +14.09% | |
| +10.82% | +12.03% | |
| Risk | ||
| 9.59% | 10.29% | |
| 1.15 | 0.94 | |
| 1.59 | 1.30 | |
| -25.02% | -12.01% | |
| Nifty 50 | — | |
| +8.38% | +8.38% | |
| 0.72 | 0.62 | |
| 94.8% | 86.4% | |
| 34.4% | 21.3% | |
| 0.74% | 0.79% | |
| ₹6,867Cr | ₹2,048Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 347% | 53% | |
| Sharwan Kumar Goyal | — | |
| 02 Jan 2013 | — | |
| 91 | — | |
| 23.6% | — | |
| 4.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.